Sympathetic nervous dysfunction in essential hypertension involves increased noradrenaline spillover, adrenaline cotransmission, and faulty noradrenaline reuptake in cardiac sympathetic nerves.
This review highlights potential pathophysiological mechanisms underlying sympathetic nervous activation in essential hypertension, including altered neurotransmitter reuptake and cotransmission.
Although the importance of sympathetic nervous activation in the pathogenesis of essential hypertension is well documented, the exact pathophysiology of the sympathetic nervous dysfunction present remains to be delineated. There are several possible explanations for the increased spillover of noradrenaline from the kidneys and heart to plasma, a key piece of evidence supporting the neurogenic basis of essential hypertension, in addition to the obvious one of an increased rate of sympathetic nerve firing. 2. The possibility that there may be an increase in the density of sympathetic innervation in human hypertension, well documented in the spontaneously hypertensive rat, is currently under investigation by us. 3. Adrenaline cotransmission is present in the cardiac sympathetic nerves of patients with essential hypertension, presumptive evidence of their exposure to high levels of stress and a possible basis for the observed increase in cardiac noradrenaline spillover, through presynaptic augmentation of noradrenaline release. 4. Phenotypic evidence exists also of faulty noradrenaline reuptake into the sympathetic nerves of the heart in essential hypertension, an abnormality that would amplify the sympathetic neural signal by impairing removal of noradrenaline from the synaptic cleft.
Esler et al. (Thu,) conducted a review in Essential hypertension. Sympathetic nervous activation was evaluated. Sympathetic nervous dysfunction in essential hypertension involves increased noradrenaline spillover, adrenaline cotransmission, and faulty noradrenaline reuptake in cardiac sympathetic nerves.